Articles published by Entrada Therapeutics, Inc.
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
Via GlobeNewswire
Tickers
TRDA
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
Via GlobeNewswire
Tickers
TRDA
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
Entrada Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare Conference
June 03, 2024
Via GlobeNewswire
Tickers
TRDA
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
Via GlobeNewswire
Tickers
TRDA
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
Via GlobeNewswire
Tickers
TRDA
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
Entrada Therapeutics to Present at Upcoming Investor Conferences
February 07, 2024
Via GlobeNewswire
Tickers
TRDA
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
Entrada Therapeutics Promotes Nathan J. Dowden to President
January 03, 2024
Via GlobeNewswire
Tickers
TRDA
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
Entrada Therapeutics Announces Updates on ENTR-601-44 in Duchenne Muscular Dystrophy
November 22, 2023
Via GlobeNewswire
Tickers
TRDA
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
Entrada Therapeutics Reports Third Quarter 2023 Financial Results
November 07, 2023
Via GlobeNewswire
Tickers
TRDA
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
Entrada Therapeutics to Present at Upcoming Investor Conferences
October 12, 2023
Via GlobeNewswire
Tickers
TRDA
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
Entrada Therapeutics to Present at Upcoming Investor Conferences
August 29, 2023
Via GlobeNewswire
Tickers
TRDA
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
Via GlobeNewswire
Tickers
TRDA
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
Via GlobeNewswire
Tickers
TRDA
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
Entrada Therapeutics to Present at Goldman Sachs 44th Annual Global Healthcare Conference
June 06, 2023
Via GlobeNewswire
Tickers
TRDA
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
Via GlobeNewswire
Tickers
TRDA
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
Via GlobeNewswire
Tickers
TRDA
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
Entrada Therapeutics to Participate in Guggenheim Genomic Medicines and Rare Disease Conference
March 29, 2023
Via GlobeNewswire
Tickers
TRDA
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
Via GlobeNewswire
Tickers
TRDA
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
Via GlobeNewswire
Tickers
TRDA
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
Entrada Therapeutics to Present at Evercore ISI 5th Annual HealthCONx Virtual Conference
November 22, 2022
Via GlobeNewswire
Tickers
TRDA
![](https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png)
Entrada Therapeutics Reports Third Quarter 2022 Financial Results
November 07, 2022
Via GlobeNewswire
Tickers
TRDA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.